|
Report No. : |
352589 |
|
Report Date : |
03.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
ONE PHARMA
TECHNOLOGIES |
|
|
|
|
Registered Office : |
8 Aflaton Street, Heliopolis, P O Box: 113618, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Year of Establishment |
2009 |
|
|
|
|
Com. Reg. No.: |
38620, Cairo |
|
|
|
|
Legal Form : |
Sole Proprietorship |
|
|
|
|
Line of Business : |
Import and
distribution of pharmaceuticals and medicines as well as offering promotional
services. |
|
|
|
|
No. of Employees : |
55 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Egypt |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : ONE PHARMA
TECHNOLOGIES
Country of Origin : Egypt
Legal Form :
Sole Proprietorship
Registration Date : 2009
Commercial
Registration Number : 38620,
Cairo
Invested Capital :
£E 100,000
Total Workforce :
55
Activities :
Distributors of pharmaceuticals, medicines and promotional services
Financial Condition : Fair
Payments :
Nothing detrimental uncovered
Operating Trend : Steady
Person Interviewed : Dr Claudy
Remoon Tarazy, Proprietor & General Manager
ONE PHARMA
TECHNOLOGIES
Street : 8 Aflaton Street
Area : Heliopolis
PO Box : 113618
Town : Cairo
Country : Egypt
Telephone : (20-2) 26903463 / 26902405
Facsimile : (20-2) 24193522
Email : c.tarazy@onepharmamed.com
/ c.tarazy@onepharamtech.com / hani.samir@onepharmatech.com
Subject operates
from a medium sized suite of offices that are rented and located in the Central
Business Area of Cairo.
Name Position
·
Dr
Claudy Remoon Tarazy Proprietor
& General Manager
·
Hani
Samir Financial
Manager
Date of Establishment : 2009
Legal Form :
Sole Proprietorship
Commercial Reg. No. : 38620, Cairo
Invested Capital
: £E 100,000
Dr Claudy Remoon
Tarazy is the sole proprietor of the business.
Activities: Engaged in the import and distribution of
pharmaceuticals and medicines as well as offering promotional services.
Import
Countries: United States of
America, United Kingdom and France
Agencies Held:
·
Mylan United States of America
·
Finox United Kingdom
·
Gerda France
Operating Trend: Steady
Subject has a
workforce of 55 employees.
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pound (£E)
Year Ending
31/12/13: Year Ending
31/12/14:
Total Sales £E 14,880,000 £E 15,325,000
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
·
Bank of
Alexandria
49 Kasr El Nile Street
Cairo
Tel: (20-2) 24824056 / 24836073
Fax:
(20-2) 24837468
No complaints
regarding subject’s payments have been reported.
During the course
of this investigation nothing detrimental was uncovered regarding subject’s operating
history or the manner in which payments are fulfilled. As such the business is
considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.62 |
|
|
1 |
Rs.100.34 |
|
Euro |
1 |
Rs.70.67 |
|
EGP |
1 |
Rs.8.51 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
HEE |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.